NCNisse V. Clark

Nisse V. Clark

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nisse V. Clark has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Jon I. Einarsson

    Massachusetts General Hospital, Boston, Massachusetts; the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Brigham and Women's Hospital, Boston, Massachusetts; the George Washington University School of Medicine and Health Sciences, Washington, DC; and Mayo Clinic, Rochester, Minnesota

    7 shared publications
  • Sarah L. Cohen

    Massachusetts General Hospital, Boston, Massachusetts; the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Brigham and Women's Hospital, Boston, Massachusetts; the George Washington University School of Medicine and Health Sciences, Washington, DC; and Mayo Clinic, Rochester, Minnesota

    6 shared publications
  • Jon Ivar Einarsson

    Boston Center for Endometriosis Boston Children's Hospital and Brigham and Women's Hospital Boston Massachusetts USA

    4 shared publications
  • Mobolaji O. Ajao

    Massachusetts General Hospital, Boston, Massachusetts; the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Brigham and Women's Hospital, Boston, Massachusetts; the George Washington University School of Medicine and Health Sciences, Washington, DC; and Mayo Clinic, Rochester, Minnesota

    4 shared publications
  • Xiangmei Gu

    Division of Minimally Invasive Gynecologic Surgery, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA

    3 shared publications
  • Kendall C. Griffith

    Division of Minimally Invasive Gynecologic Surgery, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA

    2 shared publications

Latest Publications

  • Superior Hypogastric Plexus Block to Reduce Pain After Laparoscopic Hysterectomy

    by Nisse V. Clark, Kristin Moore, Parmida Ba Maghsoudlou, Alexandra Bs North, Mobolaji O. Ajao, Jon I. Einarsson, Michelle Md Louie, Lauren Schiff, Gaby Moawad, Sarah L. Cohen, et al.

    OBJECTIVE: To assess whether a superior hypogastric plexus block performed during laparoscopic hysterectomy reduces postoperative pain. METHODS: We conducted a multicenter, randomized, single-blind, controlled trial of superior hypogastric plexus block at the start of laparoscopic hysterectomy. Women undergoing a laparoscopic hysterectomy for any indication and with any other concomitant laparoscopic procedure were eligible. Standardized preoperative medications and incisional analgesia were provided to all patients. Our primary outcome was the proportion of patients with a mean visual analog scale (VAS) pain score lower than 4 within 2 hours postoperatively. Patients but not surgeons were blinded to the treatment group. Twenty-nine patients per group was estimated to be sufficient to detect a 38% absolute difference in the proportion of patients with a VAS score lower than 4 at 2 hours postoperatively, with 80% power and an α of 0.05. To account for loss to follow-up and potential imbalances in patient characteristics, we planned to enroll 50 patients per group. All analyses were intention to treat. RESULTS: Between January 2018 and February 2019, 186 patients were eligible; 100 were randomized and analyzed. Demographic and clinical characteristics were similar between the two groups. There was no significant difference in the proportion of patients with a mean VAS score lower than 4 within 2 hours postoperatively between patients who received a superior hypogastric plexus block (57%) and patients who did not (43%) (odds ratio 1.63, 95% CI 0.74–3.59; adjusted odds ratio 1.84, 95% CI 0.75–4.51). CONCLUSION: Among patients undergoing laparoscopic hysterectomy with standardized enhanced perioperative recovery pathways, superior hypogastric plexus block did not significantly reduce postoperative pain. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT03283436.


  • Response: Lack of preoperative predictors of surgical complications in patients undergoing endometriosis surgery may be due to lack of adequate preoperative imaging

    by Nisse V. Clark, Monalisa Dmello, Kendall C. Griffith, Xiangmei Gu, Mobolaji O. Ajao, Sarah L. Cohen, Jon I. Einarsson

  • Laparoscopic treatment of endometriosis and predictors of major complications: A retrospective cohort study

    by Nisse V. Clark, Monalisa Dmello, Kendall C. Griffith, Xiangmei Gu, Mobolaji O. Ajao, Sarah L. Cohen, Jon I. Einarsson

    Introduction: Patients with advanced endometriosis may be at an increased risk of surgical complications following laparoscopic treatment of endometriosis; however, this relationship has not been examined. We sought to identify predictors of major complications following laparoscopic treatment of endometriosis.Material and methods: A retrospective cohort study of women who underwent laparoscopic treatment of suspected endometriosis between 2009 and 2016 within the Division of Minimally Invasive Gynecologic Surgery at Brigham and Women’s Hospital, Boston, MA, USA. Predictors of major perioperative complications were assessed by comparing the characteristics of women who had any major intraoperative or postoperative complication with those of women who had no complication.Results: A total of 397 women underwent laparoscopic treatment of suspected endometriosis including excision of superficial endometriosis (55.4%), excision of deep‐infiltrating endometriosis (24.9%), fulguration of endometriosis (38.3%), hysterectomy (23.2%), ovarian cystectomy (35.5%), salpingectomy (18.6%), oophorectomy (15.1%), and bowel resection (1.0%). Women were followed for 60 days following surgery, over which time 18 women (4.5%) had a major perioperative complication. Patient characteristics and preoperative imaging were similar between women with and without complications. Women with advanced endometriosis, including stage III or IV endometriosis, deep‐infiltrating endometriosis, or rectovaginal disease, were more likely to have a complication, though this did not reach statistical significance (77.8% of women with a complication versus 56.7% of women without a complication had advanced endometriosis, P = 0.077). Women who had a complication were more likely to have undergone adhesiolysis or ureterolysis (88.9% of women with a complication versus 52.5% without a complication underwent adhesiolysis, P = 0.002; and 61.1% of women with a complication versus 28.8% without a complication underwent ureterolysis, P = 0.003). The total number of procedures was greater for women who had a complication (4.3 ± 1.2 vs 3.2 ± 1.5, P = 0.003). All other procedure characteristics were similar between women with and without complications.Conclusions: Complications following laparoscopic treatment of suspected endometriosis could not be predicted by preoperative patient characteristics or surgical findings of advanced endometriosis. Adhesiolysis, ureterolysis, and an increased number of total procedures may be predictive of perioperative complications, suggesting that surgical complexity as measured by the procedures performed, rather than the disease severity, may increase the risk of a complication compared with women who do not undergo these procedures.


  • Open Access

    Perioperative Antibiotic Use and Associated Infectious Outcomes at the Time of Myomectomy

    by Annie J. Kim, Nisse V. Clark, L. Joya Jansen, Mobolaji O. Ajao, Jon I. Einarsson, Xiangmei Gu, Sarah L. Cohen

    OBJECTIVE: To report the frequency of perioperative antibiotic use at time of myomectomy and associated risk of infectious outcomes. METHODS: We conducted a retrospective cohort study including all women who underwent any route of myomectomy from 2009 to 2016 at two academic hospitals in Boston, Massachusetts. Cases involving chromopertubation or conversion to hysterectomy were excluded from further analysis. Medical records were queried for the use or nonuse of perioperative antibiotics, as well as baseline patient factors and perioperative outcomes. Statistical analyses included univariate comparisons between treatment groups, as well as multivariable logistic regression analyses of infectious morbidity controlling for patient age, route of surgery, presence of high-risk factors, any intraoperative complication, myoma weight, and entrance into the endometrial cavity. Matched cohort analysis also was performed to confirm findings in the setting of underlying differences between groups. RESULTS: A total of 1,211 patients were included in the myomectomy cohort, 92.7% of whom received perioperative antibiotics at the time of surgery. Demographic characteristics were similar between the group that received and the group that did not receive antibiotics. The cases with antibiotic use were associated with longer operative times, higher estimated blood loss, and greater myoma burden. No difference was noted with regard to intraoperative or postoperative complications. Surgical site infection occurred more commonly in the group that did not receive antibiotics (2.9% vs 6.8% in the antibiotic and no-antibiotic groups, respectively; effect size 0.43, 95% CI 0.18–0.97 P=.04), representing a nearly fourfold increase in odds of any surgical site infection in the absence of perioperative antibiotic use (adjusted odds ratio 3.77, 95% CI 1.30–10.97, P=.015). CONCLUSION: A high frequency of antibiotic use was noted at time of myomectomy, despite lack of clear evidence supporting the practice. Patients who received perioperative antibiotics had fewer postoperative infectious outcomes and, in particular, experienced a lower incidence of surgical site infection.


  • Open Access

    A Novel Technique for Essure Reversal

    by Nisse V. Clark, Jon I. Einarsson

    An increasing number of women are seeking removal of the Essure sterilization device due to symptoms including pelvic pain, abnormal bleeding, and allergic reaction. A fraction of these women also desire a future pregnancy and request sterilization reversal ...


  • Review of Sterilization Techniques and Clinical Updates

    by Nisse V. Clark, Scott P. Endicott, Elisa M. Jorgensen, Hye-Chun Hur, Ernest G. Lockrow, Mary E. Kern, Candice E. Jones-Cox, Susan G. Dunlow, Jon I. Einarsson, Sarah L. Cohen


  • The menstrual cycle and blood loss during laparoscopic myomectomy

    by Nisse V. Clark, Karen C. Wang, Jessica Opoku‐Anane, Catherine I. Hill‐Lydecker, Allison F. Vitonis, Jon I. Einarsson, Sarah L. Cohen

    Introduction: Operative morbidity of laparoscopic myomectomy largely relates to the potential for intraoperative blood loss. We sought to determine whether blood loss varies according to the menstrual cycle.Material and methods: A retrospective study of 268 women who underwent a laparoscopic myomectomy from 2007 to 2012. Patients were categorized into five menstrual groups: follicular phase, luteal phase, oligomenorrheic or amenorrheic on hormonal therapy, postmenopausal or other. Patient and procedure characteristics were compared for the follicular phase group, luteal phase group, and hormonal therapy group. The estimated blood loss was compared across the five groups using a regression model.Results: A total of 268 women underwent a laparoscopic myomectomy: 108 (40.3%) were in the follicular phase, 92 (34.3%) were in the luteal phase, 44 (16.4%) were on hormonal therapy, nine (3.4%) were postmenopausal, and 15 (5.6%) could not be classified. Baseline patient characteristics were similar between the groups with the exception of endometriosis. Geometric mean estimated blood loss was 91.9 mL in the follicular phase group, 108.7 mL in the luteal phase group, 114.1 mL in the hormonal therapy group, and 39.8 mL in the postmenopausal group. There was no significant difference in the geometric mean estimated blood loss when comparing the follilcuar phase, luteal phase, and hormonal phase groups (p = 0.41). Upon adjusted multivariable analysis of all five menstrual groups, there was also no difference in estimated blood loss.Conclusions: Intraoperative blood loss during laparoscopic myomectomy does not vary significantly with the phase of the menstrual cycle.


  • Case Report: Three-Dimensional Printed Model for Deep Infiltrating Endometriosis

    by Mobolaji O. Ajao, Nisse V. Clark, Tatiana Kelil, Sarah L. Cohen, Jon I. Einarsson